Ellerson Group’s CG Oncology CGON Stock Holding History

Ellerson Group’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Hold	3,051	–	–	0.13%	60
2026 Q1	$206K	Buy	+3,051	New	+$173K	0.14%	58

Other funds holding CGON

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Ellerson Group's CGON Position: Q2 2026 in Review

Ellerson Group held its CG Oncology (CGON) position steady in Q2 2026 at 3,051 shares worth $217K. The position accounts for 0.13% of the portfolio, ranked #60.

Ellerson Group first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

Ellerson Group held 3,051 shares of CG Oncology worth $217K as of Q2 2026.
Ellerson Group left its CG Oncology share count unchanged in Q2 2026.
CG Oncology made up 0.13% of Ellerson Group's portfolio in Q2 2026, its #60 holding.
Ellerson Group first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
56 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Ellerson Group's 13F filing for Q2 2026, filed 31 Jul 2026.